MMedXYNews
Ask AIHomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY News/Diabetes & Endocrinology

Section

Diabetes & Endocrinology

976 articles

Ask AI
All specialtiesDiabetes & EndocrinologynewsClinical UpdatesCardiologyOncology
Diabetes & Endocrinology

Refining Risk Stratification in RAS-Positive Thyroid Nodules: Clinical and Molecular Insights from a Large Surgical Cohort

In 585 RAS-mutated thyroid nodules, distinct molecular and clinical features predict malignancy risk and guide surgical management, with isolated RAS mutations showing low recurrence and potential for conservative care.

MedXY Editorial Team
Nov 14, 2026

Latest updates

Orthopedics

Impact of Vitamin D Deficiency on Bone Health in Adolescent Idiopathic Scoliosis: Insights from a 6-Year Prospective Study

Persistent severe vitamin D deficiency during adolescence in girls with idiopathic scoliosis is linked to poorer bone mineral density and compromised bone structure into early adulthood, highlighting the need for targeted interventions.

Nov 13, 2026
Oncology

Global Proposal for the TNM Staging System for Poorly Differentiated Thyroid Cancer: A Paradigm Shift in Prognostic Stratification

This comprehensive review synthesizes emerging evidence supporting a new TNM staging system tailored for poorly differentiated thyroid cancer, demonstrating enhanced prognostic accuracy over existing differentiated thyroid cancer models.

Nov 13, 2026
Diabetes & Endocrinology

Genetic Insights into Glycemic Response: Role of SLC2A2 Variants in Sulfonylurea Efficacy from the GRADE Trial

This article explores how common genetic variants near SLC2A2 affect glycemic response to glimepiride in type 2 diabetes, highlighting potential for precision medicine in second-line diabetes therapy.

Nov 12, 2026
Diabetes & Endocrinology

Retatrutide: A Promising Triple Hormone Receptor Agonist for Obesity Management and Related Comorbidities

Retatrutide, a triple agonist targeting GIP, GLP-1, and glucagon receptors, demonstrates marked weight loss and improvement in knee osteoarthritis pain and obstructive sleep apnea in adults with obesity in a phase 3 trial.

Nov 12, 2026
Diabetes & Endocrinology

Increasing Trends in Diabetes During Pregnancy and Associated Severe Maternal Morbidity in U.S. Deliveries (2016-2022)

From 2016 to 2022, gestational and pregestational diabetes prevalence rose alongside severe maternal morbidity in U.S. deliveries, with type 1 diabetes presenting the highest risk for severe complications.

Nov 11, 2026
Diabetes & Endocrinology

Enhancing Functional Capacity in Obesity: The Role of Functional Inspiratory Muscle Training

A randomized controlled trial demonstrates that functional inspiratory muscle training integrated with resistance exercise improves functional capacity and respiratory muscle performance in individuals with obesity, complementing benefits f

Nov 11, 2026
Diabetes & Endocrinology

Ectopic Cushing Syndrome: Critical Insights into Presentation, Management, and Prognosis from an International Cohort Study

This large international cohort study clarifies the clinical course, management strategies, and outcomes of ectopic Cushing syndrome, highlighting early biochemical remission as crucial for reducing mortality and complications.

Nov 10, 2026
Diabetes & Endocrinology

Early Exocrine Pancreatic Biomarker Changes in Children at Risk of Type 1 Diabetes: Insights from the ENDIA Study

The ENDIA study reveals early alterations in exocrine pancreatic biomarkers, fecal elastase-1 and serum immunoreactive trypsin, in children predisposed to type 1 diabetes, suggesting novel early disease pathogenesis markers.

Nov 9, 2026
Diabetes & Endocrinology

Bariatric Surgery as an Effective Salvage Approach Following Semaglutide or Tirzepatide Therapy Failure

Bariatric surgery offers substantial 2-year weight loss for patients with obesity who experience intolerable side effects or inadequate response to semaglutide or tirzepatide, with Roux-en-Y gastric bypass demonstrating superior outcomes in

Nov 9, 2026
Diabetes & Endocrinology

Unraveling the Heterogeneity of Adult-Onset Type 1 Diabetes: Clinical and Metabolic Subtypes Reveal New Insight for Precision Care

A prospective cohort study identifies three clinical and metabolic subtypes of recent-onset adult type 1 diabetes, revealing distinct disease dynamics, β-cell function trajectories, and complication risks that can guide personalized interve

Nov 8, 2026
Cardiology

Targeting Inflammation in Cardiovascular Risk: Efficacy and Safety of Oral NLRP3 Inhibitor Ruvonoflast

This Phase 1b trial demonstrates that oral NLRP3 inhibition with ruvonoflast markedly reduces systemic inflammatory biomarkers in obese individuals at elevated cardiovascular risk, with favorable safety and tolerability, supporting further

Nov 8, 2026
Rehabilitation Medicine

Precision in Energy Expenditure: Validating and Refining Resting Metabolic Rate Equations for Collegiate Male Wrestlers

This study cross-validates resting metabolic rate (RMR) prediction equations in Division I and III collegiate male wrestlers, developing new equations with improved accuracy to guide nutritional and training strategies.

Nov 8, 2026Sign in to read
Dermatology

Physiological vs. Supraphysiological Platelet Concentrations in Diabetic Wound Healing: Implications from a Randomized Controlled Trial

This study demonstrates that physiological concentration platelet fibrin plasma (PFP) is noninferior to supraphysiological platelet-rich plasma (PRP) in healing neuro-ischemic diabetic foot ulcers and other diabetic wounds, offering a simpl

Nov 7, 2026
Diabetes & Endocrinology

Preserving Parathyroid Function: Comparing Postoperative Hypocalcemia in Total Versus Completion Thyroidectomy

Completion thyroidectomy performed after an interval shows superior parathyroid preservation and lower postoperative hypocalcemia risk compared to initial total thyroidectomy, supporting a staged surgical approach for optimized safety.

Nov 7, 2026
Diabetes & Endocrinology

Efficacy and Safety of Oral Orforglipron in Japanese Adults with Obesity Disease: Insights from the ATTAIN-J Phase 3 Trial

The ATTAIN-J trial demonstrated that once-daily oral orforglipron significantly reduced bodyweight with a favorable safety profile in Japanese adults with obesity disease, aligning with global findings on GLP-1 receptor agonists.

Nov 7, 2026
Respiratory

Evaluating the Impact of a Self-Directed Weight Loss Intervention in Obstructive Sleep Apnea: Insights from the POWER Trial

The POWER trial assessed a self-directed lifestyle program for patients with OSA and obesity, finding modest improvements in sleep-related quality of life but limited clinically meaningful weight loss over 12 months.

Nov 6, 2026
Oncology

Evaluating Sunitinib for Advanced and Metastatic Pheochromocytomas and Paragangliomas: Efficacy, Safety, and Clinical Implications from Prospective Trials

This meta-analysis synthesizes prospective data on sunitinib treatment in metastatic pheochromocytomas and paragangliomas, revealing modest response rates and meaningful disease control with manageable safety profiles.

Nov 6, 2026
Ophthalmology

Time Course of Resolution of Diabetic Macular Edema by Sustained Suppression of VEGF-A with the Port Delivery Platform with Ranibizumab

Sustained VEGF-A suppression via the Port Delivery System with ranibizumab effectively resolves diabetic macular edema with most patients achieving edema normalization; slow resolution may mimic treatment unresponsiveness, warranting reclas

Nov 5, 2026
Diabetes & Endocrinology

Safety Profile of SGLT2 Inhibitors in Elderly Patients with Type 2 Diabetes: Insights from a Population-Based Cohort Study

This study evaluates the safety of sodium-glucose cotransporter 2 inhibitors (SGLT2is) versus DPP-4 inhibitors in adults aged 75 and older with type 2 diabetes, demonstrating favorable safety outcomes for SGLT2is without increased harm.

Nov 5, 2026
1 / 25
123…25
Next

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.